Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Zhi Liu

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Cancer Communications (London, England)|May 17, 2018
Ultrasound-guided fine needle aspiration of retropharyngeal lymph nodes after radiotherapy for nasopharyngeal carcinoma: a novel technique for accurate diagnosisLong-Jun He, Chuanbo Xie, Yin Li, et al.
Iscience|June 28, 2023
MRI-based deep learning model predicts distant metastasis and chemotherapy benefit in stage II nasopharyngeal carcinomaYu-Jun Hu, Lin Zhang, You-Ping Xiao, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2026
Long-Term Outcomes of Reduced-Dose Radiotherapy in Patients with Epstein-Barr Virus DNA-Selected Stage III Nasopharyngeal Carcinoma: A 5-Year Follow-Up Secondary Analysis of a Phase II TrialYu-Xi Xiao, Jin-Hao Yang, Xue-Song Sun, et al.
Iscience|August 7, 2024
A radiogenomic clinical decision support system to inform individualized treatment in advanced nasopharyngeal carcinomaXue-Liang Fang, Lian-Zhen Zhong, Wei Jiang, et al.
The Lancet Regional Health. Western Pacific|September 11, 2023
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trialDong-Hua Luo, Xiao-Yun Li, Shan-Shan Guo, et al.
International Journal of Cancer|May 3, 2019
Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patientsRui You, You-Ping Liu, Mei Lin, et al.
Cancer Communications (London, England)|November 16, 2019
Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinomaYou-Ping Liu, Xing Lv, Xiong Zou, et al.
The Lancet. Oncology|May 8, 2012
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysisNa Liu, Nian-Yong Chen, Rui-Xue Cui, et al.
The Lancet. Oncology|February 12, 2018
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort studyXin-Ran Tang, Ying-Qin Li, Shao-Bo Liang, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2017
Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatmentXiong Zou, Rui You, Huai Liu, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Cancer Communications (London, England)|May 17, 2018
Ultrasound-guided fine needle aspiration of retropharyngeal lymph nodes after radiotherapy for nasopharyngeal carcinoma: a novel technique for accurate diagnosisLong-Jun He, Chuanbo Xie, Yin Li, et al.
Iscience|June 28, 2023
MRI-based deep learning model predicts distant metastasis and chemotherapy benefit in stage II nasopharyngeal carcinomaYu-Jun Hu, Lin Zhang, You-Ping Xiao, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2026
Long-Term Outcomes of Reduced-Dose Radiotherapy in Patients with Epstein-Barr Virus DNA-Selected Stage III Nasopharyngeal Carcinoma: A 5-Year Follow-Up Secondary Analysis of a Phase II TrialYu-Xi Xiao, Jin-Hao Yang, Xue-Song Sun, et al.
Iscience|August 7, 2024
A radiogenomic clinical decision support system to inform individualized treatment in advanced nasopharyngeal carcinomaXue-Liang Fang, Lian-Zhen Zhong, Wei Jiang, et al.
The Lancet Regional Health. Western Pacific|September 11, 2023
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trialDong-Hua Luo, Xiao-Yun Li, Shan-Shan Guo, et al.
International Journal of Cancer|May 3, 2019
Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patientsRui You, You-Ping Liu, Mei Lin, et al.
Cancer Communications (London, England)|November 16, 2019
Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinomaYou-Ping Liu, Xing Lv, Xiong Zou, et al.
The Lancet. Oncology|May 8, 2012
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysisNa Liu, Nian-Yong Chen, Rui-Xue Cui, et al.
The Lancet. Oncology|February 12, 2018
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort studyXin-Ran Tang, Ying-Qin Li, Shao-Bo Liang, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2017
Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatmentXiong Zou, Rui You, Huai Liu, et al.
Pageof 20